| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 104,461 | 87,170 | 88,213 | 109,211 | | Cost of Revenue | 31,895 | 31,788 | 30,389 | 36,182 | | | Gross Profit | 72,566 | 55,382 | 57,824 | 73,029 | | | Operating Expenses | | Research Development | 20,071 | 19,932 | 18,973 | 9,256 | | Selling General and Administrative | 35,975 | 34,376 | 36,612 | 44,201 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,577 | 4,310 | 4,346 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,943 | (3,236) | (2,107) | 19,572 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 133 | (3,169) | (819) | 5,850 | | Earnings Before Interest And Taxes | 12,076 | (6,405) | (2,926) | 25,422 | | Interest Expense | 488 | 526 | 769 | 1,460 | | Income Before Tax | 11,588 | (6,931) | (3,695) | 23,962 | | Income Tax Expense | 3,829 | (3,369) | 437 | 11,024 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,759 | (3,562) | (4,132) | 12,938 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,759 | (3,562) | (4,132) | 12,938 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,759 | ($3,562) | ($4,132) | $12,938 |
|
0.67% Nasdaq 
Income Statement
